Table 2 Patient characteristics
No. | % | |
|---|---|---|
Gender | ||
Male | 3 | 15.8 |
Female | 16 | 84.2 |
Age | ||
Median | 58.5 | |
Range | 38–77 | |
Clinical T stage | ||
T1 | 1 | 5.3 |
T2 | 9 | 47.4 |
T3 | 5 | 26.3 |
T4 | 4 | 21.1 |
Clinical N stage | ||
N0 | 5 | 26.3 |
N1 | 6 | 31.6 |
N2 | 7 | 36.8 |
N3 | 1 | 5.3 |
No. | % | |
|---|---|---|
Gender | ||
Male | 3 | 15.8 |
Female | 16 | 84.2 |
Age | ||
Median | 58.5 | |
Range | 38–77 | |
Clinical T stage | ||
T1 | 1 | 5.3 |
T2 | 9 | 47.4 |
T3 | 5 | 26.3 |
T4 | 4 | 21.1 |
Clinical N stage | ||
N0 | 5 | 26.3 |
N1 | 6 | 31.6 |
N2 | 7 | 36.8 |
N3 | 1 | 5.3 |